Significance of soluble TNF receptor-I in acute-type fulminant hepatitis

被引:16
作者
Tokushige, K
Yamaguchi, N
Ikeda, I
Hashimoto, E
Yamauchi, K
Hayashi, N
机构
[1] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: Fulminant hepatitis is associated with apoptosis of hepatocytes, which is mediated via Fas and tumor necrosis factor (TNF) receptors. The clinical significance of apoptotic factors and these receptors was investigated in fulminant hepatitis. METHODS: Serum levels of TNF-alpha, soluble TNF receptor-I and -II, soluble Fas antigen, and Fas ligand were measured. Then, the relationships between these parameters and the severity or prognosis of fulminant hepatitis were studied. RESULTS: Serum levels of TNF-or, soluble TNF receptor-I, and soluble TNF receptor-II were increased in acute-type fulminant hepatitis. In particular, soluble TNF receptor-I was significantly higher than in patients with subacute-type fulminant hepatitis, severe acute hepatitis, acute hepatitis, or healthy controls. The soluble TNF receptor-I level continued to increase or remained high in patients who died of acute-type fulminant hepatitis, and eight of nine patients had a level >10 ng/ml. In contrast, the soluble TNF receptor-I level remained <10 ng/ml in survivors. Soluble Fas and soluble Fas ligand levels tended to increase in all types of acute liver disease and were not specific to fulminant hepatitis. CONCLUSION: Our findings suggested that monitoring the soluble TNF receptor-I level may help to assess the prognosis of acute-type fulminant hepatitis and that TNF might be associated with massive hepatic necrosis. (C) 2000 by Am. Cell. of Gastroenterology.
引用
收藏
页码:2040 / 2046
页数:7
相关论文
共 30 条
[1]
BEGG AA, 1996, SCIENCE, V274, P782
[2]
UNRAVELING FUNCTION IN THE TNF LIGAND AND RECEPTOR FAMILIES [J].
BEUTLER, B ;
VANHUFFEL, C .
SCIENCE, 1994, 264 (5159) :667-668
[3]
p75(NTR): Receptor after all [J].
Bothwell, M .
SCIENCE, 1996, 272 (5261) :506-507
[4]
PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[5]
HIRAMATSU N, 1994, HEPATOLOGY, V19, P1354, DOI 10.1002/hep.1840190606
[6]
Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure [J].
Hughes, RD ;
Nicolaou, N ;
Langley, PG ;
Ellis, AJ ;
Wendon, JA ;
Williams, R .
ARTIFICIAL ORGANS, 1998, 22 (10) :854-858
[7]
Kato J, 1996, HEPATOLOGY, V23, P389, DOI 10.1002/hep.510230301
[8]
Plasma inhibitory activity against tumour necrosis factor in fulminant hepatic failure [J].
Keane, HM ;
Sheron, N ;
Goka, J ;
Hughes, RD ;
Williams, R .
CLINICAL SCIENCE, 1996, 90 (01) :77-80
[9]
CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA (TNF), SOLUBLE TNF RECEPTORS, AND INTERLEUKIN-6 IN HUMAN SUBACUTE BACTERIAL-ENDOCARDITIS [J].
KERN, WV ;
ENGEL, A ;
SCHIEFFER, S ;
PRUMMER, O ;
KERN, P .
INFECTION AND IMMUNITY, 1993, 61 (12) :5413-5416
[10]
LANTZ M, 1994, J IMMUNOL, V152, P1362